# FDA 483 - MET Research, Inc. - June 08, 2026

Source: https://www.keypedia.com/records/483/met-research-inc/ae3eec8b-5fef-4974-b825-81bfcb0ea33e

> FDA 483 for MET Research, Inc. on June 08, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MET Research, Inc.
- Inspection Date: 2026-06-08
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations III
- Summary: Charles River Laboratories in Mattawan, MI, a nonclinical laboratory, received a Form 483 with one observation. The inspection found that the study director failed to ensure the proper transfer of all study materials to archives at the close of a study. Additionally, the study director did not document an exception from regulations in the final report's compliance statement.

## Related Documents

- [483 - 2016-04-15](https://www.keypedia.com/records/483/met-research-inc/4b345137-ce0c-4370-a8fd-5ee0db269d4c)

## Related Officers

- [investigator](https://www.keypedia.com/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)

Company: https://www.keypedia.com/companies/met-research-inc/ca40a490-7827-47f4-a765-f625114cb99a

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0